MD1664G2 - Method of ulcer recidivation prophylaxis - Google Patents
Method of ulcer recidivation prophylaxis Download PDFInfo
- Publication number
- MD1664G2 MD1664G2 MDA20000145A MD20000145A MD1664G2 MD 1664 G2 MD1664 G2 MD 1664G2 MD A20000145 A MDA20000145 A MD A20000145A MD 20000145 A MD20000145 A MD 20000145A MD 1664 G2 MD1664 G2 MD 1664G2
- Authority
- MD
- Moldova
- Prior art keywords
- ulcer
- recidivation
- prophylaxis
- antirecidivation
- gastrology
- Prior art date
Links
- 208000025865 Ulcer Diseases 0.000 title abstract 3
- 231100000397 ulcer Toxicity 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract 1
- 229910052782 aluminium Inorganic materials 0.000 abstract 1
- 239000004411 aluminium Substances 0.000 abstract 1
- 229940069428 antacid Drugs 0.000 abstract 1
- 239000003159 antacid agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical class [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 abstract 1
- 235000012254 magnesium hydroxide Nutrition 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention refers to medicine, namely to gastrology and is provided for ulcer antirecidivation treatment.The method consists in the continuous daily administration of the antacids, for example, of aluminium and magnesium hydroxides, during 2-3 years in the therapeutic effective semi-dose.The result of the invention consists in the stable and longevous ulcer remission.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20000145A MD1664G2 (en) | 2000-08-29 | 2000-08-29 | Method of ulcer recidivation prophylaxis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20000145A MD1664G2 (en) | 2000-08-29 | 2000-08-29 | Method of ulcer recidivation prophylaxis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1664F1 MD1664F1 (en) | 2001-05-31 |
| MD1664G2 true MD1664G2 (en) | 2001-11-30 |
Family
ID=19739641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20000145A MD1664G2 (en) | 2000-08-29 | 2000-08-29 | Method of ulcer recidivation prophylaxis |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1664G2 (en) |
-
2000
- 2000-08-29 MD MDA20000145A patent/MD1664G2/en unknown
Non-Patent Citations (1)
| Title |
|---|
| Приказ МЗ СССР № 770 от 30 мая 1986 года. О порядке проведения всеобщей диспансеризации населения. Москва, 1986, с. 63 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD1664F1 (en) | 2001-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MD1663B2 (en) | Composition and methods for human sexual activity modulation and impotency treatment | |
| BR0008926A (en) | Use of a grape extract, rich or enriched in polyphenols and the cosmetic treatment process of the human body | |
| GB0001309D0 (en) | Valve arrangement | |
| WO2002047703A3 (en) | Immune system stimulation | |
| IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
| MXPA04003666A (en) | Use of flibanserin in the treatment of sexual disorders. | |
| AU4180593A (en) | The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura | |
| WO1995031991A3 (en) | Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases | |
| MY164077A (en) | Compositions and uses of et743 for treating cancer | |
| GB0020504D0 (en) | Therapeutic method | |
| NZ326345A (en) | Composition containing diosgenin | |
| MD1664F1 (en) | Method of ulcer recidivation prophylaxis | |
| AU3308099A (en) | Method for the treatment of pain, including chronic and female specific pain | |
| CA2310926A1 (en) | A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease | |
| EP1161948A3 (en) | Pharmaceutical or food composition for treatment of brain edema | |
| MD916G2 (en) | Ungent for stomatologic deseases treatment | |
| BG104880A (en) | Medicamentous preparation for multiple sclerosis treatment | |
| AU2450900A (en) | Therapeutic nucleoside compound | |
| MD2491F1 (en) | Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment | |
| ZA9810603B (en) | Putamen Ovi. | |
| MD1609F1 (en) | Method of the recidivating chronic aphthous stomatitis treatment | |
| MD1854F1 (en) | Method of treatment in the congestive cardiac insufficiency | |
| MD1296F1 (en) | The Nicolau method of treatment of the lichen planus | |
| UA29155A (en) | METHOD OF TREATMENT OF THE THREAT OF PREMATURE BIRTH IN FEMALE DRUG ADDICTS | |
| MD1610F1 (en) | Method of the recidivating chronic aphthous stomatitis treatment |